Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bepirovirsen Liver Biopsy Study

NCT07696520 is registered in ClinicalTrials.gov with National University Health System, Singapore as lead sponsor.

NCT NCT07696520
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07696520 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bepirovirsen Liver Biopsy Study
Lead sponsor
National University Health System, Singapore
Phase
Phase 2
Overall status
Not yet recruiting
Start date
July 1, 2026
Completion date
April 30, 2028
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b chronic, hepatitis b chronic infection